Alector, Inc. (ALEC)
1.975
+0.14
(+7.34%)
USD |
NASDAQ |
Oct 19, 15:49
Alector EPS Diluted (Quarterly) : -0.2067 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.2067 |
| March 31, 2026 | -0.2073 |
| December 31, 2025 | -0.3403 |
| September 30, 2025 | -0.3379 |
| June 30, 2025 | -0.3041 |
| March 31, 2025 | -0.4072 |
| December 31, 2024 | -0.0211 |
| September 30, 2024 | -0.4329 |
| June 30, 2024 | -0.4001 |
| March 31, 2024 | -0.3846 |
| December 31, 2023 | -0.491 |
| September 30, 2023 | -0.5299 |
| June 30, 2023 | 0.0164 |
| March 31, 2023 | -0.5518 |
| December 31, 2022 | -0.6335 |
| September 30, 2022 | -0.5587 |
| June 30, 2022 | 0.1197 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.5434 |
| December 31, 2021 | -0.6822 |
| September 30, 2021 | 1.485 |
| June 30, 2021 | -0.6912 |
| March 31, 2021 | -0.6572 |
| December 31, 2020 | -0.6605 |
| September 30, 2020 | -0.6691 |
| June 30, 2020 | -0.578 |
| March 31, 2020 | -0.5349 |
| December 31, 2019 | -0.4497 |
| September 30, 2019 | -0.4697 |
| June 30, 2019 | -0.3648 |
| March 31, 2019 | -0.4235 |
| December 31, 2018 | -0.2491 |
| June 30, 2018 | -0.1594 |
| March 31, 2018 | -0.121 |
| December 31, 2017 | -0.1402 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.99M |
| Revenue (Quarterly) | 3.32M |
| Total Expenses (Quarterly) | 26.31M |
| Enterprise Value | 65.41M |
| Gross Profit Margin (Quarterly) | 38.28% |
| Profit Margin (Quarterly) | -692.5% |
| Earnings Yield | -55.30% |
| Normalized Earnings Yield | -52.81 |